NCT04278781 2025-10-23AG-120 in People With IDH1 Mutant ChondrosarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting6 enrolled
NCT04553692 2025-03-28Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersIGM Biosciences, Inc.Phase 1 Terminated272 enrolled